{"id":"doi:10.1056/nejmoa1501031","kind":"article","title":"Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events","authors":["Jennifer G. Robinson","Michel Farnier","Michel Krempf","Jean Bergeron","Gérald Luc","Maurizio Rocco Averna","Erik S.G. Stroes","Gisle Langslet","Frederick Johan Raal","Mahfouz El Shahawy","Michael J. Koren","Norman E. Lepor","Christelle Lorenzato","Robert C. Pordy","Umesh Chaudhari","John J.P. Kastelein"],"author_count":16,"year":2015,"published":"2015-03-15","venue":"New England Journal of Medicine","cited_by":2295,"doi":"10.1056/nejmoa1501031","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa1501031","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa1501031","updated":null,"pmid":"25773378","pmcid":null,"openalex_id":"W2001328643","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1501031?articleTools=true","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}